bromosuccinimide has been researched along with thromboxane a2 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baron, DA; Halushka, PV; Hazard, ES; Mais, DE; Mayeux, PR; Morinelli, TA; Oatis, JE; Williams, TC | 1 |
1 other study(ies) available for bromosuccinimide and thromboxane a2
| Article | Year |
|---|---|
Differential effect of pH on thromboxane A2/prostaglandin H2 receptor agonist and antagonist binding in human platelets.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Blood Platelets; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Bromosuccinimide; Carbazoles; Cell Membrane; Diethyl Pyrocarbonate; Fatty Acids, Unsaturated; Histidine; Humans; Hydrazines; Hydrogen-Ion Concentration; In Vitro Techniques; Kinetics; Ligands; Platelet Activation; Prostaglandin Endoperoxides, Synthetic; Protein Binding; Receptors, Prostaglandin; Receptors, Thromboxane; Receptors, Thromboxane A2, Prostaglandin H2; Solubility; Thromboxane A2 | 1991 |